JNJ · News · 20260914N
DePuy Synthes Divestiture
JOHNSON & JOHNSON · 2026-09-14 · Importance 58 · Surprise 42 · In source text
Johnson & Johnson is reportedly in non-binding discussions to sell its DePuy Synthes orthopedics business to Apollo Global Management for approximately $20 billion. DePuy Synthes generated $9.3 billion in sales in 2025 and produces joint-replacement implants and surgical instruments. The potential sale would advance J&J’s previously announced plan to separate the orthopedics unit and focus on higher-growth pharmaceuticals and medical devices.
Key facts
- Johnson & Johnson is reportedly close to selling its DePuy Synthes orthopedics business to Apollo Equity Management for approximately $20 billion. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | positive | contingent | +1.5% | Johnson & Johnson is reportedly close to selling its DePuy Synthes orthopedics business to Apollo Equity Management for approximately $20… |